WGU D027
Advanced
Pathopharmacolog
ical Foundations
(WGU) 2025 –
Practice Questions
with Answers and
Rationales
This document covers key concepts from Advanced Pathopharmacological Foundations,
including neurological, gastrointestinal, respiratory, endocrine, and psychiatric disorders. It
presents high-yield exam-style questions with clear answers and rationales to support
understanding and retention.
The material aligns with common WGU D027 exam topics and provides a comprehensive
review for exam preparation.
Page 1 of 217 3/18/2026, 6:24:26 PM
, Questions, Answers, and Rationales
1. What are the physical changes seen in Alzheimer’s dementia?
Answer:
● Brain atrophy (shrinkage)
● Nerve cell death and tissue loss
● Presence of plaques and tangles
Rationale:
Alzheimer’s disease is characterized by neurodegeneration. Beta-amyloid plaques and
neurofibrillary tangles disrupt neuron communication, leading to progressive brain shrinkage
and cognitive decline.
2. How is Alzheimer’s disease treated?
Answer:
● Cholinesterase inhibitors
● Memantine (Namenda)
● Supportive/nonpharmacologic care
Rationale:
There is no cure. Treatment focuses on slowing progression and improving symptoms by
enhancing neurotransmitter activity or regulating excitatory pathways.
3. What do cholinesterase inhibitors do?
Answer:
● Prevent breakdown of acetylcholine
Rationale:
Acetylcholine is essential for memory and learning. Increasing its availability improves
communication between neurons and slows symptom progression.
4. Which cholinesterase inhibitor is used in all stages of Alzheimer’s?
Answer:
● Donepezil
Rationale:
Donepezil is approved for mild, moderate, and severe Alzheimer’s due to its broader
efficacy.
Page 2 of 217 3/18/2026, 6:24:26 PM
, 5. What is the mechanism of action of memantine?
Answer:
● Regulates glutamate activity
Rationale:
Excess glutamate causes neuronal damage. Memantine protects neurons by preventing
overstimulation.
6. What is ataxia?
Answer:
● A neurological disorder causing impaired coordination
Rationale:
Damage to the cerebellum affects balance and motor control, leading to symptoms like
slurred speech and unsteady movement.
7. What is the primary cause of symptoms in ataxia?
Answer:
● Cerebellar damage
Rationale:
The cerebellum coordinates voluntary movement; damage leads to loss of coordination.
8. What is celiac disease?
Answer:
● Autoimmune disorder triggered by gluten
Rationale:
Gluten ingestion causes immune-mediated damage to the small intestine, leading to
malabsorption.
9. What is the gold standard test for celiac disease?
Answer:
● IgA-tTG and duodenal biopsy
Page 3 of 217 3/18/2026, 6:24:26 PM
, Rationale:
Serologic testing detects antibodies, while biopsy confirms intestinal damage.
10. What is the treatment for celiac disease?
Answer:
● Lifelong gluten-free diet
Rationale:
Removing gluten eliminates the immune response and allows intestinal healing.
11. What distinguishes Crohn’s disease from ulcerative colitis?
Answer:
● Crohn’s: affects entire GI tract, skip lesions
● UC: affects colon only, continuous inflammation
Rationale:
Crohn’s involves transmural inflammation and patchy lesions, while UC is limited to the
colon’s inner lining.
12. What is the first-line treatment for COPD?
Answer:
● Short-acting bronchodilators
Rationale:
These medications provide rapid symptom relief by relaxing airway smooth muscle.
13. What is emphysema?
Answer:
● Destruction of alveoli
Rationale:
Loss of alveolar elasticity leads to air trapping and impaired gas exchange.
14. What is asthma?
Answer:
● Reversible airway inflammation and bronchoconstriction
Page 4 of 217 3/18/2026, 6:24:26 PM
Advanced
Pathopharmacolog
ical Foundations
(WGU) 2025 –
Practice Questions
with Answers and
Rationales
This document covers key concepts from Advanced Pathopharmacological Foundations,
including neurological, gastrointestinal, respiratory, endocrine, and psychiatric disorders. It
presents high-yield exam-style questions with clear answers and rationales to support
understanding and retention.
The material aligns with common WGU D027 exam topics and provides a comprehensive
review for exam preparation.
Page 1 of 217 3/18/2026, 6:24:26 PM
, Questions, Answers, and Rationales
1. What are the physical changes seen in Alzheimer’s dementia?
Answer:
● Brain atrophy (shrinkage)
● Nerve cell death and tissue loss
● Presence of plaques and tangles
Rationale:
Alzheimer’s disease is characterized by neurodegeneration. Beta-amyloid plaques and
neurofibrillary tangles disrupt neuron communication, leading to progressive brain shrinkage
and cognitive decline.
2. How is Alzheimer’s disease treated?
Answer:
● Cholinesterase inhibitors
● Memantine (Namenda)
● Supportive/nonpharmacologic care
Rationale:
There is no cure. Treatment focuses on slowing progression and improving symptoms by
enhancing neurotransmitter activity or regulating excitatory pathways.
3. What do cholinesterase inhibitors do?
Answer:
● Prevent breakdown of acetylcholine
Rationale:
Acetylcholine is essential for memory and learning. Increasing its availability improves
communication between neurons and slows symptom progression.
4. Which cholinesterase inhibitor is used in all stages of Alzheimer’s?
Answer:
● Donepezil
Rationale:
Donepezil is approved for mild, moderate, and severe Alzheimer’s due to its broader
efficacy.
Page 2 of 217 3/18/2026, 6:24:26 PM
, 5. What is the mechanism of action of memantine?
Answer:
● Regulates glutamate activity
Rationale:
Excess glutamate causes neuronal damage. Memantine protects neurons by preventing
overstimulation.
6. What is ataxia?
Answer:
● A neurological disorder causing impaired coordination
Rationale:
Damage to the cerebellum affects balance and motor control, leading to symptoms like
slurred speech and unsteady movement.
7. What is the primary cause of symptoms in ataxia?
Answer:
● Cerebellar damage
Rationale:
The cerebellum coordinates voluntary movement; damage leads to loss of coordination.
8. What is celiac disease?
Answer:
● Autoimmune disorder triggered by gluten
Rationale:
Gluten ingestion causes immune-mediated damage to the small intestine, leading to
malabsorption.
9. What is the gold standard test for celiac disease?
Answer:
● IgA-tTG and duodenal biopsy
Page 3 of 217 3/18/2026, 6:24:26 PM
, Rationale:
Serologic testing detects antibodies, while biopsy confirms intestinal damage.
10. What is the treatment for celiac disease?
Answer:
● Lifelong gluten-free diet
Rationale:
Removing gluten eliminates the immune response and allows intestinal healing.
11. What distinguishes Crohn’s disease from ulcerative colitis?
Answer:
● Crohn’s: affects entire GI tract, skip lesions
● UC: affects colon only, continuous inflammation
Rationale:
Crohn’s involves transmural inflammation and patchy lesions, while UC is limited to the
colon’s inner lining.
12. What is the first-line treatment for COPD?
Answer:
● Short-acting bronchodilators
Rationale:
These medications provide rapid symptom relief by relaxing airway smooth muscle.
13. What is emphysema?
Answer:
● Destruction of alveoli
Rationale:
Loss of alveolar elasticity leads to air trapping and impaired gas exchange.
14. What is asthma?
Answer:
● Reversible airway inflammation and bronchoconstriction
Page 4 of 217 3/18/2026, 6:24:26 PM
